Endoluminal Suturing Devices Market: Growth Factors, Segmentation, Trends, Opportunities, Key Players and Forecast The global endoluminal suturing devices market is expected to grow from $1.1 billion in 2021 to $1.5 billion in 2026, at a CAGR of 8.6%. The market is driven by the increasing number of surgeries, the rising incidence of colorectal cancer, and the growing demand for minimally invasive procedures. Key growth factors: * Increasing number of surgeries: The global endoluminal suturing devices market is driven by the increasing number of surgeries. Endoluminal suturing devices are used in a variety of surgeries, including colorectal cancer surgery, bariatric surgery, and gynecological surgery. * Rising incidence of colorectal cancer: The global endoluminal suturing devices market is also driven by the rising incidence of colorectal cancer. Colorectal cancer is the third most common cancer in the world, and it is the second leading cause of cancer death. Endoluminal suturing devices are used to treat colorectal cancer by closing the wound after surgery. * Growing demand for minimally invasive procedures: The global endoluminal suturing devices market is also driven by the growing demand for minimally invasive procedures. Minimally invasive procedures are less invasive than traditional open surgery, and they are associated with shorter recovery times and lower risk of complications. Endoluminal suturing devices are used in minimally invasive procedures to close wounds and to prevent bleeding. Key segmentation: The global endoluminal suturing devices market is segmented by product type, application, and region. * By product type, the market is segmented into sutures, clips, and staplers. Sutures are the most common type of endoluminal suturing devices, and they are used to close wounds. Clips are used to seal blood vessels, and staplers are used to close incisions. * By application, the market is segmented into colorectal cancer surgery, bariatric surgery, and gynecological surgery. Colorectal cancer surgery is the largest application for endoluminal suturing devices, and it is expected to remain the largest application over the forecast period. Bariatric surgery is the second largest application for endoluminal suturing devices, and it is expected to grow at a CAGR of 9.5% over the forecast period. Gynecological surgery is the third largest application for endoluminal suturing devices, and it is expected to grow at a CAGR of 8.0% over the forecast period. * By region, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is the largest market for endoluminal suturing devices, and it is expected to remain the largest market over the forecast period. Europe is the second largest market for endoluminal suturing devices, and it is expected to grow at a CAGR of 8.2% over the forecast period. Asia-Pacific is the third largest market for endoluminal suturing devices, and it is expected to grow at a CAGR of 9.0% over the forecast period. The Rest of the World is the smallest market for endoluminal suturing devices, and it is expected to grow at a CAGR of 7.8% over the forecast period. Key players: The key players in the global endoluminal suturing devices market include Medtronic, Boston Scientific, Ethicon, and Johnson & Johnson. These companies have a strong presence in the market, and they are expected to continue to dominate the market over the forecast period. Endoluminal suturing devices are used to close wounds and to prevent bleeding in a variety of surgeries. The market is expected to grow at a CAGR of 8.6% over the forecast period. The key growth factors include the increasing number of surgeries, the rising incidence of colorectal cancer, and the growing demand for minimally invasive procedures.